AbbVie Files Patent Suit Over Amgen’s Copy of Humira – Wall Street Journal


Wall Street Journal
AbbVie Files Patent Suit Over Amgen's Copy of Humira
Wall Street Journal
The lawsuit, filed late Thursday in federal court in Delaware, alleges Amgen's copy of the biotech drug Humira violates many of AbbVie's patents on the anti-inflammatory treatment. The suit asks the court to keep the copy off the market if it gains
AbbVie files patent lawsuit seeking to stop Amgen's copy of HumiraSeeking Alpha
AbbVie Sues Amgen to Fend Off Copy of Blockbuster HumiraBloomberg

all 10 news articles »

Leave a Reply

Your email address will not be published. Required fields are marked *